Investigation of the Ototoxic Effect of Pembrolizumab Using a Rat Model

Objective Programmed cell death protein-1 (PD-1) inhibitors that have been recently introduced for the systemic treatment of head and neck cancers offer the advantage of fewer side effects and more effective treatment than chemotherapy drugs. A review of the literature shows that the ototoxic side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzucu, İhsan, Baklacı, Deniz, Guler, İsmail, Uçaryılmaz, Esra Özhamam, Kum, Rauf Oğuzhan, Özcan, Müge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890160/
https://www.ncbi.nlm.nih.gov/pubmed/31827988
http://dx.doi.org/10.7759/cureus.6057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890160/
https://www.ncbi.nlm.nih.gov/pubmed/31827988
http://dx.doi.org/10.7759/cureus.6057

Ejemplares similares